217 related articles for article (PubMed ID: 25730719)
1. Screening for prevention and early diagnosis of cancer.
Wardle J; Robb K; Vernon S; Waller J
Am Psychol; 2015; 70(2):119-33. PubMed ID: 25730719
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
3. U.S. women's perceived importance of the harms and benefits of mammograms and associations with screening ambivalence: Results from a national survey.
Qin X; Nagler RH; Fowler EF; Gollust SE
Prev Med; 2019 Jun; 123():130-137. PubMed ID: 30890352
[TBL] [Abstract][Full Text] [Related]
4. Presentation of Benefits and Harms in US Cancer Screening and Prevention Guidelines: Systematic Review.
Caverly TJ; Hayward RA; Reamer E; Zikmund-Fisher BJ; Connochie D; Heisler M; Fagerlin A
J Natl Cancer Inst; 2016 Jun; 108(6):djv436. PubMed ID: 26917630
[TBL] [Abstract][Full Text] [Related]
5. Mammography screening. Benefits, harms, and informed choice.
Jørgensen KJ
Dan Med J; 2013 Apr; 60(4):B4614. PubMed ID: 23651722
[TBL] [Abstract][Full Text] [Related]
6. Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial.
Pérez-Lacasta MJ; Martínez-Alonso M; Garcia M; Sala M; Perestelo-Pérez L; Vidal C; Codern-Bové N; Feijoo-Cid M; Toledo-Chávarri A; Cardona À; Pons A; Carles-Lavila M; Rue M;
PLoS One; 2019; 14(3):e0214057. PubMed ID: 30913217
[TBL] [Abstract][Full Text] [Related]
7. How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial.
Hersch J; McGeechan K; Barratt A; Jansen J; Irwig L; Jacklyn G; Houssami N; Dhillon H; McCaffery K
BMJ Open; 2017 Oct; 7(10):e016246. PubMed ID: 28988168
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Lung Cancer Screening Program Websites.
Clark SD; Reuland DS; Enyioha C; Jonas DE
JAMA Intern Med; 2020 Jun; 180(6):824-830. PubMed ID: 32282024
[TBL] [Abstract][Full Text] [Related]
9. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
[TBL] [Abstract][Full Text] [Related]
10. Do invitations for cervical screening provide sufficient information to enable informed choice? A cross-sectional study of invitations for publicly funded cervical screening.
Kolthoff SK; Hestbech MS; Jørgensen KJ; Brodersen J
J R Soc Med; 2016 Jul; 109(7):274-81. PubMed ID: 27118696
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.
Onega T; Beaber EF; Sprague BL; Barlow WE; Haas JS; Tosteson AN; D Schnall M; Armstrong K; Schapira MM; Geller B; Weaver DL; Conant EF
Cancer; 2014 Oct; 120(19):2955-64. PubMed ID: 24830599
[TBL] [Abstract][Full Text] [Related]
12. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Population-based screening for cancer: hope and hype.
Shieh Y; Eklund M; Sawaya GF; Black WC; Kramer BS; Esserman LJ
Nat Rev Clin Oncol; 2016 Sep; 13(9):550-65. PubMed ID: 27071351
[TBL] [Abstract][Full Text] [Related]
15. Perspectives of Screening-Eligible Women and Male Partners on Benefits of and Barriers to Treatment for Precancerous Lesions and Cervical Cancer in Kenya.
Ragan KR; Buchanan Lunsford N; Lee Smith J; Saraiya M; Aketch M
Oncologist; 2018 Jan; 23(1):35-43. PubMed ID: 28798272
[TBL] [Abstract][Full Text] [Related]
16. Decision-making about mammographic screening: pursuing informed choice.
Hersch J; Jansen J; McCaffery K
Climacteric; 2018 Jun; 21(3):209-213. PubMed ID: 29419315
[TBL] [Abstract][Full Text] [Related]
17. Uninformed compliance or informed choice? A needed shift in our approach to cancer screening.
Stefanek ME
J Natl Cancer Inst; 2011 Dec; 103(24):1821-6. PubMed ID: 22106094
[TBL] [Abstract][Full Text] [Related]
18. [Screening for colorectal, skin, breast and prostate cancer. Essential knowledge for counseling].
Hübner J; Noftz MR; Schnoor M; Katalinic A
Internist (Berl); 2014 Oct; 55(10):1171-81. PubMed ID: 25256406
[TBL] [Abstract][Full Text] [Related]
19. Patient-Reported Factors Associated With Older Adults' Cancer Screening Decision-making: A Systematic Review.
Smith J; Dodd RH; Gainey KM; Naganathan V; Cvejic E; Jansen J; McCaffery KJ
JAMA Netw Open; 2021 Nov; 4(11):e2133406. PubMed ID: 34748004
[TBL] [Abstract][Full Text] [Related]
20. The four steps in the prevention of human papillomavirus-associated neoplasia: considerations for preventive measures, screening, disease impact, and potential overtreatments in HPV-related pathology.
Liverani CA
Arch Gynecol Obstet; 2013 Nov; 288(5):979-88. PubMed ID: 23974280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
